Literature DB >> 8044826

Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma.

F W Hill1, V P Rutten, M H Hoyer, W R Klein, J W Koten, P A Steerenberg, E J Ruitenberg, W Den Otter.   

Abstract

Thirty cows from a pedigree Friesian dairy herd with bovine vulva papilloma and carcinoma were treated by intralesional injections of live bacillus Calmette-Guérin (BCG). This treatment induced total regression of all of six carcinomas. Whilst, after treatment, limited regression was also observed in advanced papillomas, BCG has little or no effect on the early stages of papillomas. This is the first study of BCG therapy in this type of cancer.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8044826     DOI： 10.1007/bf01517180

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


  10 in total

1.  Regression of bovine vulval squamous cell carcinoma after immunotherapy.

Authors:  J L Samuel
Journal:  Aust Vet J       Date:  1989-06       Impact factor: 1.281

2.  Attempted immunotherapy and autotransplantation of bovine vulval squamous cell carcinoma.

Authors:  P A Jennings; D Hoffmann; B E Wilson
Journal:  Aust Vet J       Date:  1979-12       Impact factor: 1.281

3.  [Bovine vulval carcinoma in Ceylon (author's transl)].

Authors:  S G Wettimuny
Journal:  Zentralbl Veterinarmed A       Date:  1974-11

4.  Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine.

Authors:  S J Kleinschuster; H J Rapp; D C Lueker; R A Kainer
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

5.  Local interleukin-2 therapy in bovine ocular squamous cell carcinoma. A pilot study.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; W Den Otter; P A Steerenberg; W H De Jong; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.

Authors:  W R Klein; E J Ruitenberg; P A Steerenberg; W H de Jong; W Kruizinga; W Misdorp; J Bier; R H Tiesjema; J G Kreeftenberg; J S Teppema; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

7.  Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Authors:  V P Rutten; W R Klein; W A De Jong; W Misdorp; P A Steerenberg; W H De Jong; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer.

Authors:  W J Catalona; M A Hudson; D P Gillen; G L Andriole; T L Ratliff
Journal:  J Urol       Date:  1987-02       Impact factor: 7.450

9.  Efficacy of intratumorally administered mycobacterial cell walls in the treatment of cattle with ocular carcinoma.

Authors:  S J Kleinschuster; H J Rapp; S B Green; J Bier; K van Kampen
Journal:  J Natl Cancer Inst       Date:  1981-11       Impact factor: 13.506

10.  Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma.

Authors:  F W Hill; W R Klein; M J Hoyer; V P Rutten; N Kock; J W Koten; P A Steerenberg; E J Ruitenberg; W Den Otter
Journal:  Vet Immunol Immunopathol       Date:  1994-05       Impact factor: 2.046
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.